Victory Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,272
| Closed | -$221K | – | 2606 |
|
|
2020
Q2 | $221K | Sell |
12,272
-125,850
| -91% | -$1.75M | ﹤0.01% | 2272 |
|
|
2020
Q1 | $984K | Buy |
138,122
+64,511
| +88% | +$805K | ﹤0.01% | 1854 |
|
|
2019
Q4 | $1.76M | Buy |
73,611
+2,525
| +4% | +$69.7K | ﹤0.01% | 1556 |
|
|
2019
Q3 | $1.91M | Buy |
71,086
+69,547
| +4,519% | +$1.95M | ﹤0.01% | 1484 |
|
|
2019
Q2 | $42K | Hold |
1,539
| – | – | ﹤0.01% | 1756 |
|
|
2019
Q1 | $53K | Hold |
1,539
| – | – | ﹤0.01% | 1709 |
|
|
2018
Q4 | $30K | Sell |
1,539
-293
| -16% | -$6.03K | ﹤0.01% | 1729 |
|
|
2018
Q3 | $49K | Buy |
1,832
+241
| +15% | +$7.87K | ﹤0.01% | 1727 |
|
|
2018
Q2 | $60K | Hold |
1,591
| – | – | ﹤0.01% | 1747 |
|
|
2018
Q1 | $52K | Hold |
1,591
| – | – | ﹤0.01% | 1745 |
|
|
2017
Q4 | $77K | Buy |
1,591
+326
| +26% | +$16.5K | ﹤0.01% | 1721 |
|
|
2017
Q3 | $68K | Hold |
1,265
| – | – | ﹤0.01% | 1724 |
|
|
2017
Q2 | $71K | Buy |
1,265
+22
| +2% | +$881 | ﹤0.01% | 1712 |
|
|
2017
Q1 | $49K | Buy |
1,243
+194
| +18% | +$6.18K | ﹤0.01% | 1731 |
|
|
2016
Q4 | $24K | Buy |
1,049
+59
| +6% | +$1.15K | ﹤0.01% | 1746 |
|
|
2016
Q3 | $22K | Buy |
990
+66
| +7% | +$1.55K | ﹤0.01% | 1746 |
|
|
2016
Q2 | $22K | Buy |
924
+137
| +17% | +$3.38K | ﹤0.01% | 1594 |
|
|
2016
Q1 | $16K | Buy |
787
+63
| +9% | +$2K | ﹤0.01% | 1628 |
|
|
2015
Q4 | $37K | Buy |
724
+39
| +6% | +$1.89K | ﹤0.01% | 1608 |
|
|
2015
Q3 | $29K | Buy |
685
+51
| +8% | +$2.46K | ﹤0.01% | 1568 |
|
|
2015
Q2 | $29K | Buy |
+634
| New | +$25.5K | ﹤0.01% | 1575 |
|
Victory Capital Management's PTLA Position: Q3 2020 in Review
Victory Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 12,272 shares — an estimated $221K sold.
Victory Capital Management first reported a position in PTLA in Q2 2015 and held it in 21 quarters. The position peaked at $1.91M in Q3 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Victory Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Victory Capital Management sold 12,272 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $221K.
- Victory Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 21 quarters.
- Victory Capital Management's Portola Pharmaceuticals, Inc. position peaked at $1.91M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Victory Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.